MMI pockets $125m to back its robotic microsurgery’s market growth
Florida-based robotics specialist, MMI, has banked $125m in a Series D funding round, financially fortifying the company as it looks to…
All articles by Annabel Kartal Allen
Annabel Kartal Allen
Annabel Kartal-Allen is a reporter for Clinical Trials Arena, Pharmaceutical Technology and Medical Device Network based in London, UK. Annabel holds interests in oncology, neurology and metabolic diseases. She has previous experience reporting for both the pharmaceutical and nutraceutical industries, and holds a BSc in Biology from the University of Sussex. Contact Annabel
-
-
Eye implant sight improvements in GA continue for 36 months, pivotal study finds
Science Corporation’s subretinal implant and specialised glasses combination, PRIMA, has been shown to provide durable, long-term gains in vision to…
-
UK government backs healthcare commission blueprint for AI-enabled devices
The UK government has opted to accept all the recommendations made by its specialist healthcare-focused artificial intelligence (AI) commission around…
-
Brainomix’s e-Lung shows progression and treatment response in Phase III trial
Brainomix has debuted data from a Phase III progressive pulmonary fibrosis (PPF) study that highlights the ability of its artificial…
-
Podcast: Continuous monitoring’s burgeoning role in metabolic health
In recent years, the way many patients manage their diabetes has undergone a fundamental shift, with the role of wearables…
-
Patients want flexible and involved cardiac care, but cost hurdles remain
A new survey from digital health company Vivalink has found that patients with cardiac conditions favour flexible-home based cardiac rehabilitation…
-
Australia starts investigation into OpenAI Medicare breach
The Australian government has initiated a review into a hacking incident in which tech giant OpenAI’s artificial intelligence (AI) model…
-
Podcast: Developing non-invasive therapies for glioblastoma
While researchers and drug developers have made several efforts to develop effective treatments for glioblastoma (GBM), the standard of care…
-
Agentic AI trust gap slowing healthcare provider adoption, survey reveals
A new survey from digital healthcare security specialist Imprivata has revealed that, while artificial intelligence (AI) is now becoming commonplace…
-
Apollo rumoured to be eyeing $20bn takeover of J&J’s orthopaedics business
Alternative asset management company Apollo Global Management is reportedly in talks to acquire Johnson & Johnson’s (J&J) orthopaedics unit through…